与老年人药物戒断不良事件相关的医院再入院:试点研究
D'Arcy Mellors1, Despina Antonas1, Patrick Russell2
1SA Pharmacy, Adelaide, SA, Australia.
International journal of clinical pharmacy
|October 29, 2025
概括
药物戒断不良事件 (ADWE) 导致近一半的老年人重入医院. 心脏药物,特别是利尿剂,经常涉及,强调需要更好地识别和预防策略.
科学领域:
- 老年医学 老年医学
- 临床药理学 临床药理学
- 患者安全 患者安全
背景情况:
- 与毒品相关的住院治疗是频繁的,其中很大一部分是可以预防的.
- 药物戒断不良事件 (ADWE) 是这些住院住院的常见但未被充分研究的原因.
- ADWE包括戒断反应或药物停止或剂量减少后潜在疾病的复发.
研究的目的:
- 在老年人中试点评估ADWE.
- 确定与ADWE相关的医院再入院的比例.
- 探索ADWEs有助于再接收的特征.
主要方法:
- 对三个月内两次入院的老年患者进行了回顾性病例笔记审查.
- 查抑郁症事件 (停止,减少剂量,替代).
- 由两名审查员进行的独立评估,以确认ADWE的发生和对再接收的贡献.
主要成果:
- 在12个重新录取中的5个 (41.6%) 可能是由ADWEs贡献的.
- 心脏药物,特别是利尿剂,与大多数ADWE相关的再入院有关.
- 33个抑郁症事件中有7个 (21%) 可能导致ADWE,其中6个有助于重新入院.
结论:
- ADWE似乎是复杂老年人再入院的重要因素.
- 进一步的研究对于识别和预防ADWE至关重要.
- 这项试点研究强调了需要积极主动的抑郁症描述策略的需要.
相关概念视频
Drug Dosing: Geriatric Patients
219
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
219
Pharmacodynamics in Geriatric Patients: Effects of Age
183
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
183
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
223
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
223
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
232
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
232
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
227
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
227
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
194
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
194


